nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefepime—SLC22A5—Organic cation transport—SLC22A18—breast cancer	0.00781	0.148	CbGpPWpGaD
Cefepime—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A18—breast cancer	0.0053	0.1	CbGpPWpGaD
Cefepime—SLC15A2—mammary gland—breast cancer	0.00361	0.0952	CbGeAlD
Cefepime—SLC15A1—epithelium—breast cancer	0.00321	0.0848	CbGeAlD
Cefepime—SLC22A5—mammary gland—breast cancer	0.00314	0.0828	CbGeAlD
Cefepime—SLC15A1—endometrium—breast cancer	0.00288	0.076	CbGeAlD
Cefepime—SLC22A5—nipple—breast cancer	0.0026	0.0685	CbGeAlD
Cefepime—SLC15A1—endocrine gland—breast cancer	0.00202	0.0533	CbGeAlD
Cefepime—SLC15A2—endometrium—breast cancer	0.0018	0.0475	CbGeAlD
Cefepime—SLC22A5—skin of body—breast cancer	0.00166	0.0439	CbGeAlD
Cefepime—SLC15A2—pituitary gland—breast cancer	0.00163	0.043	CbGeAlD
Cefepime—SLC22A5—endometrium—breast cancer	0.00157	0.0413	CbGeAlD
Cefepime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A7—breast cancer	0.00156	0.0296	CbGpPWpGaD
Cefepime—SLC15A2—female reproductive system—breast cancer	0.00149	0.0394	CbGeAlD
Cefepime—SLC15A2—adrenal gland—breast cancer	0.00146	0.0384	CbGeAlD
Cefepime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A7—breast cancer	0.00145	0.0274	CbGpPWpGaD
Cefepime—SLC22A5—pituitary gland—breast cancer	0.00142	0.0374	CbGeAlD
Cefepime—SLC22A5—adipose tissue—breast cancer	0.00141	0.0373	CbGeAlD
Cefepime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A10—breast cancer	0.0014	0.0265	CbGpPWpGaD
Cefepime—SLC15A2—female gonad—breast cancer	0.00136	0.0358	CbGeAlD
Cefepime—SLC22A5—female reproductive system—breast cancer	0.0013	0.0343	CbGeAlD
Cefepime—SLC22A5—adrenal gland—breast cancer	0.00127	0.0334	CbGeAlD
Cefepime—SLC15A2—endocrine gland—breast cancer	0.00126	0.0333	CbGeAlD
Cefepime—SLC22A5—female gonad—breast cancer	0.00118	0.0312	CbGeAlD
Cefepime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A7—breast cancer	0.00116	0.022	CbGpPWpGaD
Cefepime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—breast cancer	0.00106	0.0201	CbGpPWpGaD
Cefepime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A5—breast cancer	0.00102	0.0194	CbGpPWpGaD
Cefepime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—breast cancer	0.000879	0.0167	CbGpPWpGaD
Cefepime—SLC15A2—lymph node—breast cancer	0.000873	0.023	CbGeAlD
Cefepime—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—breast cancer	0.000802	0.0152	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000762	0.0145	CbGpPWpGaD
Cefepime—SLC22A5—lymph node—breast cancer	0.000759	0.02	CbGeAlD
Cefepime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—breast cancer	0.000745	0.0141	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000707	0.0134	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000697	0.0132	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000697	0.0132	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000696	0.0132	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000647	0.0123	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000647	0.0123	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000636	0.0121	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000636	0.0121	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000578	0.011	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000536	0.0102	CbGpPWpGaD
Cefepime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	0.000529	0.01	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000528	0.01	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000527	0.01	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000509	0.00964	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000509	0.00964	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.00049	0.0093	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000482	0.00914	CbGpPWpGaD
Cefepime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—breast cancer	0.000473	0.00896	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000472	0.00895	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000472	0.00895	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000464	0.0088	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000464	0.0088	CbGpPWpGaD
Cefepime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—breast cancer	0.000439	0.00832	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000438	0.0083	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000406	0.0077	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.0004	0.00758	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000387	0.00734	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000359	0.00682	CbGpPWpGaD
Cefepime—Nausea—Goserelin—breast cancer	0.000358	0.000394	CcSEcCtD
Cefepime—Dysgeusia—Capecitabine—breast cancer	0.000357	0.000393	CcSEcCtD
Cefepime—Feeling abnormal—Gemcitabine—breast cancer	0.000357	0.000393	CcSEcCtD
Cefepime—Shock—Paclitaxel—breast cancer	0.000357	0.000393	CcSEcCtD
Cefepime—Dizziness—Vinorelbine—breast cancer	0.000357	0.000392	CcSEcCtD
Cefepime—Thrombocytopenia—Paclitaxel—breast cancer	0.000355	0.000391	CcSEcCtD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000354	0.00672	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000354	0.00672	CbGpPWpGaD
Cefepime—Urticaria—Mitoxantrone—breast cancer	0.000354	0.000389	CcSEcCtD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000353	0.0067	CbGpPWpGaD
Cefepime—Diarrhoea—Thiotepa—breast cancer	0.000353	0.000388	CcSEcCtD
Cefepime—Body temperature increased—Irinotecan—breast cancer	0.000352	0.000387	CcSEcCtD
Cefepime—Body temperature increased—Mitoxantrone—breast cancer	0.000352	0.000387	CcSEcCtD
Cefepime—Abdominal pain—Mitoxantrone—breast cancer	0.000352	0.000387	CcSEcCtD
Cefepime—Abdominal pain—Irinotecan—breast cancer	0.000352	0.000387	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Doxorubicin—breast cancer	0.000352	0.000387	CcSEcCtD
Cefepime—Feeling abnormal—Fluorouracil—breast cancer	0.000351	0.000386	CcSEcCtD
Cefepime—Bronchitis—Epirubicin—breast cancer	0.000351	0.000386	CcSEcCtD
Cefepime—Pneumonia—Methotrexate—breast cancer	0.00035	0.000385	CcSEcCtD
Cefepime—Anaemia—Docetaxel—breast cancer	0.000348	0.000383	CcSEcCtD
Cefepime—Pancytopenia—Epirubicin—breast cancer	0.000347	0.000381	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000345	0.000379	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Doxorubicin—breast cancer	0.000345	0.000379	CcSEcCtD
Cefepime—Vomiting—Vinorelbine—breast cancer	0.000343	0.000377	CcSEcCtD
Cefepime—Body temperature increased—Gemcitabine—breast cancer	0.000343	0.000377	CcSEcCtD
Cefepime—Renal failure—Methotrexate—breast cancer	0.000342	0.000376	CcSEcCtD
Cefepime—Neutropenia—Epirubicin—breast cancer	0.000341	0.000375	CcSEcCtD
Cefepime—Dizziness—Thiotepa—breast cancer	0.000341	0.000375	CcSEcCtD
Cefepime—Rash—Vinorelbine—breast cancer	0.00034	0.000374	CcSEcCtD
Cefepime—Dermatitis—Vinorelbine—breast cancer	0.00034	0.000374	CcSEcCtD
Cefepime—Urticaria—Fluorouracil—breast cancer	0.000339	0.000372	CcSEcCtD
Cefepime—Headache—Vinorelbine—breast cancer	0.000338	0.000372	CcSEcCtD
Cefepime—Leukopenia—Docetaxel—breast cancer	0.000337	0.000371	CcSEcCtD
Cefepime—Anaemia—Capecitabine—breast cancer	0.000337	0.000371	CcSEcCtD
Cefepime—Body temperature increased—Fluorouracil—breast cancer	0.000337	0.000371	CcSEcCtD
Cefepime—Eosinophilia—Doxorubicin—breast cancer	0.000334	0.000368	CcSEcCtD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000329	0.00623	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000329	0.00623	CbGpPWpGaD
Cefepime—Hypersensitivity—Irinotecan—breast cancer	0.000328	0.000361	CcSEcCtD
Cefepime—Hypersensitivity—Mitoxantrone—breast cancer	0.000328	0.000361	CcSEcCtD
Cefepime—Vomiting—Thiotepa—breast cancer	0.000328	0.00036	CcSEcCtD
Cefepime—Pneumonia—Epirubicin—breast cancer	0.000327	0.00036	CcSEcCtD
Cefepime—Leukopenia—Capecitabine—breast cancer	0.000327	0.000359	CcSEcCtD
Cefepime—Convulsion—Docetaxel—breast cancer	0.000327	0.000359	CcSEcCtD
Cefepime—Paraesthesia—Paclitaxel—breast cancer	0.000326	0.000358	CcSEcCtD
Cefepime—Rash—Thiotepa—breast cancer	0.000325	0.000357	CcSEcCtD
Cefepime—Bronchitis—Doxorubicin—breast cancer	0.000325	0.000357	CcSEcCtD
Cefepime—Dermatitis—Thiotepa—breast cancer	0.000325	0.000357	CcSEcCtD
Cefepime—Agranulocytosis—Methotrexate—breast cancer	0.000324	0.000357	CcSEcCtD
Cefepime—Dyspnoea—Paclitaxel—breast cancer	0.000324	0.000356	CcSEcCtD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000323	0.00613	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000323	0.00613	CbGpPWpGaD
Cefepime—Headache—Thiotepa—breast cancer	0.000323	0.000355	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000323	0.000355	CcSEcCtD
Cefepime—Pancytopenia—Doxorubicin—breast cancer	0.000321	0.000353	CcSEcCtD
Cefepime—Nausea—Vinorelbine—breast cancer	0.000321	0.000352	CcSEcCtD
Cefepime—Renal failure—Epirubicin—breast cancer	0.00032	0.000352	CcSEcCtD
Cefepime—Urinary tract infection—Epirubicin—breast cancer	0.000316	0.000348	CcSEcCtD
Cefepime—Neutropenia—Doxorubicin—breast cancer	0.000316	0.000347	CcSEcCtD
Cefepime—Hypersensitivity—Fluorouracil—breast cancer	0.000314	0.000345	CcSEcCtD
Cefepime—Haemoglobin—Methotrexate—breast cancer	0.000314	0.000345	CcSEcCtD
Cefepime—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000313	0.000345	CcSEcCtD
Cefepime—Haemorrhage—Methotrexate—breast cancer	0.000312	0.000343	CcSEcCtD
Cefepime—Constipation—Paclitaxel—breast cancer	0.00031	0.000341	CcSEcCtD
Cefepime—Pain—Paclitaxel—breast cancer	0.00031	0.000341	CcSEcCtD
Cefepime—Confusional state—Docetaxel—breast cancer	0.00031	0.000341	CcSEcCtD
Cefepime—Anaphylactic shock—Docetaxel—breast cancer	0.000308	0.000338	CcSEcCtD
Cefepime—Pruritus—Gemcitabine—breast cancer	0.000307	0.000337	CcSEcCtD
Cefepime—Nausea—Thiotepa—breast cancer	0.000306	0.000337	CcSEcCtD
Cefepime—Infection—Docetaxel—breast cancer	0.000306	0.000336	CcSEcCtD
Cefepime—Diarrhoea—Irinotecan—breast cancer	0.000304	0.000335	CcSEcCtD
Cefepime—Diarrhoea—Mitoxantrone—breast cancer	0.000304	0.000335	CcSEcCtD
Cefepime—Agranulocytosis—Epirubicin—breast cancer	0.000304	0.000334	CcSEcCtD
Cefepime—Pneumonia—Doxorubicin—breast cancer	0.000303	0.000333	CcSEcCtD
Cefepime—Shock—Docetaxel—breast cancer	0.000303	0.000333	CcSEcCtD
Cefepime—Pruritus—Fluorouracil—breast cancer	0.000302	0.000332	CcSEcCtD
Cefepime—Thrombocytopenia—Docetaxel—breast cancer	0.000301	0.000331	CcSEcCtD
Cefepime—Confusional state—Capecitabine—breast cancer	0.0003	0.00033	CcSEcCtD
Cefepime—Feeling abnormal—Paclitaxel—breast cancer	0.000299	0.000329	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000298	0.000328	CcSEcCtD
Cefepime—Gastrointestinal pain—Paclitaxel—breast cancer	0.000297	0.000326	CcSEcCtD
Cefepime—Diarrhoea—Gemcitabine—breast cancer	0.000297	0.000326	CcSEcCtD
Cefepime—Renal failure—Doxorubicin—breast cancer	0.000296	0.000325	CcSEcCtD
Cefepime—Infection—Capecitabine—breast cancer	0.000296	0.000325	CcSEcCtD
Cefepime—Erythema multiforme—Methotrexate—breast cancer	0.000295	0.000325	CcSEcCtD
Cefepime—Dizziness—Irinotecan—breast cancer	0.000294	0.000324	CcSEcCtD
Cefepime—Haemoglobin—Epirubicin—breast cancer	0.000294	0.000323	CcSEcCtD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000294	0.00557	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—COX11—breast cancer	0.000294	0.00557	CbGpPWpGaD
Cefepime—Shock—Capecitabine—breast cancer	0.000293	0.000322	CcSEcCtD
Cefepime—Urinary tract infection—Doxorubicin—breast cancer	0.000293	0.000322	CcSEcCtD
Cefepime—Haemorrhage—Epirubicin—breast cancer	0.000292	0.000321	CcSEcCtD
Cefepime—Diarrhoea—Fluorouracil—breast cancer	0.000292	0.000321	CcSEcCtD
Cefepime—Thrombocytopenia—Capecitabine—breast cancer	0.000292	0.000321	CcSEcCtD
Cefepime—Urticaria—Paclitaxel—breast cancer	0.000288	0.000317	CcSEcCtD
Cefepime—Abdominal pain—Paclitaxel—breast cancer	0.000287	0.000316	CcSEcCtD
Cefepime—Body temperature increased—Paclitaxel—breast cancer	0.000287	0.000316	CcSEcCtD
Cefepime—Vomiting—Irinotecan—breast cancer	0.000283	0.000311	CcSEcCtD
Cefepime—Vomiting—Mitoxantrone—breast cancer	0.000283	0.000311	CcSEcCtD
Cefepime—Dizziness—Fluorouracil—breast cancer	0.000282	0.00031	CcSEcCtD
Cefepime—Agranulocytosis—Doxorubicin—breast cancer	0.000281	0.000309	CcSEcCtD
Cefepime—Rash—Irinotecan—breast cancer	0.000281	0.000309	CcSEcCtD
Cefepime—Rash—Mitoxantrone—breast cancer	0.000281	0.000309	CcSEcCtD
Cefepime—Dermatitis—Irinotecan—breast cancer	0.00028	0.000308	CcSEcCtD
Cefepime—Dermatitis—Mitoxantrone—breast cancer	0.00028	0.000308	CcSEcCtD
Cefepime—Chills—Methotrexate—breast cancer	0.00028	0.000308	CcSEcCtD
Cefepime—Headache—Irinotecan—breast cancer	0.000279	0.000307	CcSEcCtD
Cefepime—Headache—Mitoxantrone—breast cancer	0.000279	0.000307	CcSEcCtD
Cefepime—Paraesthesia—Docetaxel—breast cancer	0.000276	0.000304	CcSEcCtD
Cefepime—Erythema multiforme—Epirubicin—breast cancer	0.000276	0.000304	CcSEcCtD
Cefepime—Vomiting—Gemcitabine—breast cancer	0.000276	0.000303	CcSEcCtD
Cefepime—Dyspnoea—Docetaxel—breast cancer	0.000274	0.000302	CcSEcCtD
Cefepime—Rash—Gemcitabine—breast cancer	0.000273	0.000301	CcSEcCtD
Cefepime—Dermatitis—Gemcitabine—breast cancer	0.000273	0.0003	CcSEcCtD
Cefepime—SLC15A1—Transmembrane transport of small molecules—COX11—breast cancer	0.000272	0.00517	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000272	0.00517	CbGpPWpGaD
Cefepime—Erythema—Methotrexate—breast cancer	0.000272	0.000299	CcSEcCtD
Cefepime—Haemoglobin—Doxorubicin—breast cancer	0.000272	0.000299	CcSEcCtD
Cefepime—Headache—Gemcitabine—breast cancer	0.000272	0.000299	CcSEcCtD
Cefepime—Vomiting—Fluorouracil—breast cancer	0.000271	0.000298	CcSEcCtD
Cefepime—Haemorrhage—Doxorubicin—breast cancer	0.00027	0.000297	CcSEcCtD
Cefepime—Rash—Fluorouracil—breast cancer	0.000269	0.000296	CcSEcCtD
Cefepime—Dermatitis—Fluorouracil—breast cancer	0.000269	0.000295	CcSEcCtD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000268	0.00509	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000268	0.00508	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—COX11—breast cancer	0.000268	0.00508	CbGpPWpGaD
Cefepime—Paraesthesia—Capecitabine—breast cancer	0.000267	0.000294	CcSEcCtD
Cefepime—Hypersensitivity—Paclitaxel—breast cancer	0.000267	0.000294	CcSEcCtD
Cefepime—Headache—Fluorouracil—breast cancer	0.000267	0.000294	CcSEcCtD
Cefepime—Dysgeusia—Methotrexate—breast cancer	0.000266	0.000293	CcSEcCtD
Cefepime—Gastrointestinal disorder—Docetaxel—breast cancer	0.000266	0.000292	CcSEcCtD
Cefepime—Dyspnoea—Capecitabine—breast cancer	0.000266	0.000292	CcSEcCtD
Cefepime—Nausea—Irinotecan—breast cancer	0.000264	0.000291	CcSEcCtD
Cefepime—Nausea—Mitoxantrone—breast cancer	0.000264	0.000291	CcSEcCtD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000263	0.00499	CbGpPWpGaD
Cefepime—Pain—Docetaxel—breast cancer	0.000263	0.000289	CcSEcCtD
Cefepime—Constipation—Docetaxel—breast cancer	0.000263	0.000289	CcSEcCtD
Cefepime—Chills—Epirubicin—breast cancer	0.000262	0.000288	CcSEcCtD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000258	0.0049	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000258	0.0049	CbGpPWpGaD
Cefepime—Nausea—Gemcitabine—breast cancer	0.000258	0.000283	CcSEcCtD
Cefepime—Gastrointestinal disorder—Capecitabine—breast cancer	0.000257	0.000283	CcSEcCtD
Cefepime—Pruritus—Paclitaxel—breast cancer	0.000257	0.000282	CcSEcCtD
Cefepime—Erythema multiforme—Doxorubicin—breast cancer	0.000256	0.000281	CcSEcCtD
Cefepime—Pain—Capecitabine—breast cancer	0.000255	0.00028	CcSEcCtD
Cefepime—Constipation—Capecitabine—breast cancer	0.000255	0.00028	CcSEcCtD
Cefepime—Erythema—Epirubicin—breast cancer	0.000254	0.00028	CcSEcCtD
Cefepime—Feeling abnormal—Docetaxel—breast cancer	0.000254	0.000279	CcSEcCtD
Cefepime—Nausea—Fluorouracil—breast cancer	0.000253	0.000278	CcSEcCtD
Cefepime—Gastrointestinal pain—Docetaxel—breast cancer	0.000252	0.000277	CcSEcCtD
Cefepime—Anaemia—Methotrexate—breast cancer	0.000251	0.000276	CcSEcCtD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000249	0.00472	CbGpPWpGaD
Cefepime—Dysgeusia—Epirubicin—breast cancer	0.000249	0.000274	CcSEcCtD
Cefepime—Diarrhoea—Paclitaxel—breast cancer	0.000248	0.000273	CcSEcCtD
Cefepime—Feeling abnormal—Capecitabine—breast cancer	0.000245	0.00027	CcSEcCtD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000245	0.00465	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000244	0.00463	CbGpPWpGaD
Cefepime—Gastrointestinal pain—Capecitabine—breast cancer	0.000244	0.000268	CcSEcCtD
Cefepime—Abdominal pain—Docetaxel—breast cancer	0.000243	0.000267	CcSEcCtD
Cefepime—Body temperature increased—Docetaxel—breast cancer	0.000243	0.000267	CcSEcCtD
Cefepime—Leukopenia—Methotrexate—breast cancer	0.000243	0.000267	CcSEcCtD
Cefepime—Chills—Doxorubicin—breast cancer	0.000242	0.000267	CcSEcCtD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.00024	0.00456	CbGpPWpGaD
Cefepime—Dizziness—Paclitaxel—breast cancer	0.00024	0.000264	CcSEcCtD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.00024	0.00455	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.00024	0.00455	CbGpPWpGaD
Cefepime—Urticaria—Capecitabine—breast cancer	0.000237	0.00026	CcSEcCtD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000236	0.00447	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000236	0.00447	CbGpPWpGaD
Cefepime—Body temperature increased—Capecitabine—breast cancer	0.000235	0.000259	CcSEcCtD
Cefepime—Abdominal pain—Capecitabine—breast cancer	0.000235	0.000259	CcSEcCtD
Cefepime—Convulsion—Methotrexate—breast cancer	0.000235	0.000259	CcSEcCtD
Cefepime—Erythema—Doxorubicin—breast cancer	0.000235	0.000259	CcSEcCtD
Cefepime—Anaemia—Epirubicin—breast cancer	0.000235	0.000258	CcSEcCtD
Cefepime—Agitation—Epirubicin—breast cancer	0.000234	0.000257	CcSEcCtD
Cefepime—Vomiting—Paclitaxel—breast cancer	0.000231	0.000254	CcSEcCtD
Cefepime—Dysgeusia—Doxorubicin—breast cancer	0.00023	0.000253	CcSEcCtD
Cefepime—Rash—Paclitaxel—breast cancer	0.000229	0.000252	CcSEcCtD
Cefepime—Dermatitis—Paclitaxel—breast cancer	0.000229	0.000251	CcSEcCtD
Cefepime—Leukopenia—Epirubicin—breast cancer	0.000228	0.00025	CcSEcCtD
Cefepime—Headache—Paclitaxel—breast cancer	0.000227	0.00025	CcSEcCtD
Cefepime—Hypersensitivity—Docetaxel—breast cancer	0.000227	0.000249	CcSEcCtD
Cefepime—Confusional state—Methotrexate—breast cancer	0.000224	0.000246	CcSEcCtD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000222	0.00422	CbGpPWpGaD
Cefepime—Anaphylactic shock—Methotrexate—breast cancer	0.000222	0.000244	CcSEcCtD
Cefepime—Convulsion—Epirubicin—breast cancer	0.00022	0.000242	CcSEcCtD
Cefepime—Infection—Methotrexate—breast cancer	0.00022	0.000242	CcSEcCtD
Cefepime—Hypersensitivity—Capecitabine—breast cancer	0.000219	0.000241	CcSEcCtD
Cefepime—Pruritus—Docetaxel—breast cancer	0.000218	0.000239	CcSEcCtD
Cefepime—Anaemia—Doxorubicin—breast cancer	0.000217	0.000239	CcSEcCtD
Cefepime—Thrombocytopenia—Methotrexate—breast cancer	0.000217	0.000239	CcSEcCtD
Cefepime—Agitation—Doxorubicin—breast cancer	0.000216	0.000238	CcSEcCtD
Cefepime—Nausea—Paclitaxel—breast cancer	0.000216	0.000237	CcSEcCtD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000211	0.004	CbGpPWpGaD
Cefepime—Pruritus—Capecitabine—breast cancer	0.000211	0.000232	CcSEcCtD
Cefepime—Leukopenia—Doxorubicin—breast cancer	0.000211	0.000232	CcSEcCtD
Cefepime—Diarrhoea—Docetaxel—breast cancer	0.00021	0.000231	CcSEcCtD
Cefepime—Confusional state—Epirubicin—breast cancer	0.000209	0.00023	CcSEcCtD
Cefepime—Anaphylactic shock—Epirubicin—breast cancer	0.000208	0.000228	CcSEcCtD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000206	0.00391	CbGpPWpGaD
Cefepime—Infection—Epirubicin—breast cancer	0.000206	0.000227	CcSEcCtD
Cefepime—Shock—Epirubicin—breast cancer	0.000204	0.000224	CcSEcCtD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000204	0.00387	CbGpPWpGaD
Cefepime—Convulsion—Doxorubicin—breast cancer	0.000204	0.000224	CcSEcCtD
Cefepime—Diarrhoea—Capecitabine—breast cancer	0.000204	0.000224	CcSEcCtD
Cefepime—SLC15A2—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000203	0.00386	CbGpPWpGaD
Cefepime—Dizziness—Docetaxel—breast cancer	0.000203	0.000224	CcSEcCtD
Cefepime—Thrombocytopenia—Epirubicin—breast cancer	0.000203	0.000223	CcSEcCtD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000203	0.00385	CbGpPWpGaD
Cefepime—Paraesthesia—Methotrexate—breast cancer	0.000199	0.000219	CcSEcCtD
Cefepime—Dyspnoea—Methotrexate—breast cancer	0.000198	0.000217	CcSEcCtD
Cefepime—Dizziness—Capecitabine—breast cancer	0.000197	0.000217	CcSEcCtD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000196	0.00372	CbGpPWpGaD
Cefepime—Vomiting—Docetaxel—breast cancer	0.000196	0.000215	CcSEcCtD
Cefepime—Rash—Docetaxel—breast cancer	0.000194	0.000213	CcSEcCtD
Cefepime—Dermatitis—Docetaxel—breast cancer	0.000194	0.000213	CcSEcCtD
Cefepime—Confusional state—Doxorubicin—breast cancer	0.000194	0.000213	CcSEcCtD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000193	0.00365	CbGpPWpGaD
Cefepime—Headache—Docetaxel—breast cancer	0.000193	0.000212	CcSEcCtD
Cefepime—Anaphylactic shock—Doxorubicin—breast cancer	0.000192	0.000211	CcSEcCtD
Cefepime—Gastrointestinal disorder—Methotrexate—breast cancer	0.000191	0.000211	CcSEcCtD
Cefepime—Infection—Doxorubicin—breast cancer	0.000191	0.00021	CcSEcCtD
Cefepime—Pain—Methotrexate—breast cancer	0.00019	0.000209	CcSEcCtD
Cefepime—Vomiting—Capecitabine—breast cancer	0.000189	0.000208	CcSEcCtD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000189	0.00359	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000189	0.00359	CbGpPWpGaD
Cefepime—Shock—Doxorubicin—breast cancer	0.000189	0.000208	CcSEcCtD
Cefepime—SLC15A1—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000189	0.00358	CbGpPWpGaD
Cefepime—Thrombocytopenia—Doxorubicin—breast cancer	0.000188	0.000207	CcSEcCtD
Cefepime—Rash—Capecitabine—breast cancer	0.000188	0.000207	CcSEcCtD
Cefepime—Dermatitis—Capecitabine—breast cancer	0.000188	0.000206	CcSEcCtD
Cefepime—Headache—Capecitabine—breast cancer	0.000187	0.000205	CcSEcCtD
Cefepime—Paraesthesia—Epirubicin—breast cancer	0.000186	0.000205	CcSEcCtD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000186	0.00353	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000186	0.00352	CbGpPWpGaD
Cefepime—Dyspnoea—Epirubicin—breast cancer	0.000185	0.000203	CcSEcCtD
Cefepime—Nausea—Docetaxel—breast cancer	0.000183	0.000201	CcSEcCtD
Cefepime—Feeling abnormal—Methotrexate—breast cancer	0.000183	0.000201	CcSEcCtD
Cefepime—Gastrointestinal pain—Methotrexate—breast cancer	0.000181	0.000199	CcSEcCtD
Cefepime—Gastrointestinal disorder—Epirubicin—breast cancer	0.000179	0.000197	CcSEcCtD
Cefepime—Pain—Epirubicin—breast cancer	0.000177	0.000195	CcSEcCtD
Cefepime—Constipation—Epirubicin—breast cancer	0.000177	0.000195	CcSEcCtD
Cefepime—Nausea—Capecitabine—breast cancer	0.000177	0.000195	CcSEcCtD
Cefepime—Urticaria—Methotrexate—breast cancer	0.000176	0.000194	CcSEcCtD
Cefepime—SLC15A1—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000176	0.00333	CbGpPWpGaD
Cefepime—Body temperature increased—Methotrexate—breast cancer	0.000175	0.000193	CcSEcCtD
Cefepime—Abdominal pain—Methotrexate—breast cancer	0.000175	0.000193	CcSEcCtD
Cefepime—SLC22A5—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000173	0.00327	CbGpPWpGaD
Cefepime—Paraesthesia—Doxorubicin—breast cancer	0.000172	0.00019	CcSEcCtD
Cefepime—Dyspnoea—Doxorubicin—breast cancer	0.000171	0.000188	CcSEcCtD
Cefepime—Feeling abnormal—Epirubicin—breast cancer	0.000171	0.000188	CcSEcCtD
Cefepime—Gastrointestinal pain—Epirubicin—breast cancer	0.00017	0.000187	CcSEcCtD
Cefepime—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000166	0.000182	CcSEcCtD
Cefepime—Urticaria—Epirubicin—breast cancer	0.000165	0.000181	CcSEcCtD
Cefepime—Pain—Doxorubicin—breast cancer	0.000164	0.000181	CcSEcCtD
Cefepime—Constipation—Doxorubicin—breast cancer	0.000164	0.000181	CcSEcCtD
Cefepime—Abdominal pain—Epirubicin—breast cancer	0.000164	0.00018	CcSEcCtD
Cefepime—Body temperature increased—Epirubicin—breast cancer	0.000164	0.00018	CcSEcCtD
Cefepime—Hypersensitivity—Methotrexate—breast cancer	0.000163	0.00018	CcSEcCtD
Cefepime—SLC15A2—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000161	0.00305	CbGpPWpGaD
Cefepime—Feeling abnormal—Doxorubicin—breast cancer	0.000158	0.000174	CcSEcCtD
Cefepime—Gastrointestinal pain—Doxorubicin—breast cancer	0.000157	0.000173	CcSEcCtD
Cefepime—Pruritus—Methotrexate—breast cancer	0.000157	0.000173	CcSEcCtD
Cefepime—Hypersensitivity—Epirubicin—breast cancer	0.000153	0.000168	CcSEcCtD
Cefepime—Urticaria—Doxorubicin—breast cancer	0.000153	0.000168	CcSEcCtD
Cefepime—Body temperature increased—Doxorubicin—breast cancer	0.000152	0.000167	CcSEcCtD
Cefepime—Abdominal pain—Doxorubicin—breast cancer	0.000152	0.000167	CcSEcCtD
Cefepime—Diarrhoea—Methotrexate—breast cancer	0.000152	0.000167	CcSEcCtD
Cefepime—SLC15A1—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000149	0.00283	CbGpPWpGaD
Cefepime—Pruritus—Epirubicin—breast cancer	0.000147	0.000161	CcSEcCtD
Cefepime—SLC22A5—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000147	0.00278	CbGpPWpGaD
Cefepime—Dizziness—Methotrexate—breast cancer	0.000147	0.000161	CcSEcCtD
Cefepime—Diarrhoea—Epirubicin—breast cancer	0.000142	0.000156	CcSEcCtD
Cefepime—Hypersensitivity—Doxorubicin—breast cancer	0.000141	0.000156	CcSEcCtD
Cefepime—Vomiting—Methotrexate—breast cancer	0.000141	0.000155	CcSEcCtD
Cefepime—Rash—Methotrexate—breast cancer	0.00014	0.000154	CcSEcCtD
Cefepime—Dermatitis—Methotrexate—breast cancer	0.00014	0.000154	CcSEcCtD
Cefepime—Headache—Methotrexate—breast cancer	0.000139	0.000153	CcSEcCtD
Cefepime—Dizziness—Epirubicin—breast cancer	0.000137	0.000151	CcSEcCtD
Cefepime—Pruritus—Doxorubicin—breast cancer	0.000136	0.000149	CcSEcCtD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000134	0.00254	CbGpPWpGaD
Cefepime—Vomiting—Epirubicin—breast cancer	0.000132	0.000145	CcSEcCtD
Cefepime—Nausea—Methotrexate—breast cancer	0.000132	0.000145	CcSEcCtD
Cefepime—Diarrhoea—Doxorubicin—breast cancer	0.000131	0.000144	CcSEcCtD
Cefepime—SLC15A2—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000131	0.00249	CbGpPWpGaD
Cefepime—Rash—Epirubicin—breast cancer	0.000131	0.000144	CcSEcCtD
Cefepime—Dermatitis—Epirubicin—breast cancer	0.000131	0.000144	CcSEcCtD
Cefepime—Headache—Epirubicin—breast cancer	0.00013	0.000143	CcSEcCtD
Cefepime—Dizziness—Doxorubicin—breast cancer	0.000127	0.00014	CcSEcCtD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000124	0.00235	CbGpPWpGaD
Cefepime—Nausea—Epirubicin—breast cancer	0.000123	0.000136	CcSEcCtD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000122	0.00232	CbGpPWpGaD
Cefepime—Vomiting—Doxorubicin—breast cancer	0.000122	0.000134	CcSEcCtD
Cefepime—SLC15A1—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000122	0.00231	CbGpPWpGaD
Cefepime—Rash—Doxorubicin—breast cancer	0.000121	0.000133	CcSEcCtD
Cefepime—Dermatitis—Doxorubicin—breast cancer	0.000121	0.000133	CcSEcCtD
Cefepime—Headache—Doxorubicin—breast cancer	0.00012	0.000132	CcSEcCtD
Cefepime—SLC22A5—Transmembrane transport of small molecules—ABCG2—breast cancer	0.00012	0.00227	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—TFRC—breast cancer	0.000117	0.00222	CbGpPWpGaD
Cefepime—Nausea—Doxorubicin—breast cancer	0.000114	0.000125	CcSEcCtD
Cefepime—SLC15A2—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000112	0.00213	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—TFRC—breast cancer	0.000108	0.00206	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000107	0.00203	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—TFRC—breast cancer	0.000107	0.00202	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000104	0.00198	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000104	0.00197	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000103	0.00195	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—ALB—breast cancer	0.000101	0.00191	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	9.96e-05	0.00189	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC5A5—breast cancer	9.79e-05	0.00186	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	9.62e-05	0.00182	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—NCOA1—breast cancer	9.48e-05	0.0018	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC2A1—breast cancer	9.46e-05	0.00179	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—ALB—breast cancer	9.35e-05	0.00177	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—PLG—breast cancer	9.24e-05	0.00175	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—ALB—breast cancer	9.19e-05	0.00174	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—NCOA1—breast cancer	8.8e-05	0.00167	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—NCOA1—breast cancer	8.65e-05	0.00164	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—PLG—breast cancer	8.57e-05	0.00163	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—HMOX1—breast cancer	8.52e-05	0.00162	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—PLG—breast cancer	8.43e-05	0.0016	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—ABCB1—breast cancer	8.18e-05	0.00155	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—HMOX1—breast cancer	7.91e-05	0.0015	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—HMOX1—breast cancer	7.78e-05	0.00148	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—ABCB1—breast cancer	7.59e-05	0.00144	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—ABCB1—breast cancer	7.47e-05	0.00142	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—ALB—breast cancer	5.12e-05	0.000971	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—ALB—breast cancer	4.75e-05	0.000901	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—ALB—breast cancer	4.67e-05	0.000886	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—RAF1—breast cancer	4.63e-05	0.000878	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—RAF1—breast cancer	4.3e-05	0.000815	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—RAF1—breast cancer	4.22e-05	0.000801	CbGpPWpGaD
